Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
463-01-011 ISMRM Abstract

Hybrid 2D CNN-Transformer Achieves Fast and Robust Ktrans Mapping of FUS-Induced BBB Opening

Primary: Acquisition & Reconstruction - Image Reconstruction: AI
Secondary: Diffusion - Diffusion Analysis & Visualization
463-01-011 · Data-Driven Reconstruction: From Networks to Clinical Practice · Tuesday, 12 May, 8:20 AM–9:15 AM · Digital Posters Row D
Keywords: Permeability Machine Learning/Artificial Intelligence Dynamic contrast enhanced MRI Blood-brain barrier Animal mouse model
Accepted
Akito Yamauchi1, Zongyu Li 2, Zhonghui Qie3, Jia Guo2,4
1Columbia University, New York, United States of America
2Department of Biomedical Engineering, Columbia University, New York, United States of America
3Zuckerman Institute, Columbia University, New York, United States of America
4Department of Psychiatry, Columbia University, New York, United States of America
Presenting Author: Zongyu Li

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. LeWitt, Peter A., Nir Lipsman, and Jeffrey H. Kordower. "Focused ultrasound opening of the blood–brain barrier for treatment of Parkinson's disease." Movement Disorders 34.9 (2019): 1274-1278. DOI: https://doi.org/10.1002/mds.27722 [doi]
2. Iadecola, Costantino. "Neurovascular regulation in the normal brain and in Alzheimer's disease." Nature Reviews Neuroscience 5.5 (2004): 347-360. DOI: https://doi.org/10.1038/nrn1387 [doi]
3. Pardridge, William M. "Molecular Trojan horses for blood–brain barrier drug delivery." Current opinion in pharmacology 6.5 (2006): 494-500. DOI: https://doi.org/10.1016/j.coph.2006.06.001 [doi]
4. Pardridge, William M. "The blood-brain barrier: bottleneck in brain drug development." NeuroRx 2.1 (2005): 3-14. DOI: https://doi.org/10.1602/neurorx.2.1.3 [doi]
5. Papademetriou, Iason T., and Tyrone Porter. "Promising approaches to circumvent the blood–brain barrier: progress, pitfalls and clinical prospects in brain cancer." Therapeutic delivery 6.8 (2015): 989-1016. DOI: https://doi.org/10.4155/tde.15.48 [doi]
6. Vlachos, Fotios, Yao‐Sheng Tung, and Elisa Konofagou. "Permeability dependence study of the focused ultrasound‐induced blood–brain barrier opening at distinct pressures and microbubble diameters using DCE‐MRI." Magnetic resonance in medicine 66.3 (2011): 821-830. DOI: https://doi.org/10.1002/mrm.22848 [doi]
7. Grobner, Thomas. "Gadolinium–a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?." Nephrology Dialysis Transplantation 21.4 (2006): 1104-1108. DOI: https://doi.org/10.1093/ndt/gfk062 [doi]
8. Yang, Lucie, et al. "Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration." Radiology 265.1 (2012): 248-253. DOI: https://doi.org/10.1148/radiol.12112783 [doi]
9. Lee, Pin-Yu, et al. "Deep learning enables reduced gadolinium dose for contrast-enhanced blood-brain barrier opening quantitative measurement." 2024 IEEE International Symposium on Biomedical Imaging (ISBI). IEEE, 2024. PMID: 36713234 [pmid]
10. Zhu, Jiachen, et al. "Transformers without normalization." Proceedings of the Computer Vision and Pattern Recognition Conference. 2025. DOI: https://doi.org/10.48550/arXiv.2503.10622 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/463-01-011